The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-14 of 14 articles
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa Jr J,
Abizaid A,
Bartorelli A,
Whitbourn R,
Jepson N,
Perin M,
Steinwender C,
Stuteville M,
Ediebah D,
Sudhir K,
Serruys P
November 20, 2016 | 10.4244/EIJV12I10A206
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A,
Costa Jr J,
Bartorelli A,
Whitbourn R,
van Geuns R,
Chevalier B,
Patel T,
Seth A,
Stuteville M,
Dorange C,
Cheong W-F,
Sudhir K,
Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial
Yamasaki M,
Tsujino I,
Lima-Filho M,
Ako J,
Shimohama T,
Hasegawa T,
Sakurai R,
Sudhir K,
Stone G,
Waseda K,
Honda Y,
Fitzgerald P
October 26, 2012 | 10.4244/EIJV8I6A112
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
Morice M,
Mikhail G,
Mauri i Ferr F,
Modena M,
Strasser R,
Grinfeld L,
Sudhir K,
Stuteville M,
Papeleu P,
Li D,
Rutledge D,
Windecker S
July 27, 2012 | 10.4244/EIJV8I3A51
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials
Hermiller J,
Sudhir K,
Applegate R,
Rizvi A,
Wang J,
Gordon P,
Yaqub M,
Cao S,
Ferguson J,
Smith R,
Sood P,
MPhil M,
Stone G
May 15, 2012 | 10.4244/EIJV8I1A14
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents
January 20, 2012 | 10.4244/EIJV7I9A165
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S,
Garcia-Garcia H,
Diletti R,
Gomez-Lara J,
Garg S,
Onuma Y,
Shin E,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Chevalier B,
McClean D,
Windecker S,
Whitbourn R,
Dorange C,
Veldhof S,
Rapoza R,
Sudhir K,
Bruining N,
Ormiston J,
Serruys P
April 20, 2011
In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial
Okamura T,
Garg S,
Gutiérrez-Chico J-L,
Shin E,
Onuma Y,
Garcia-Garcia H,
Rapoza R,
Sudhir K,
Regar E,
Serruys P
April 12, 2010
A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis
Seth A,
Serruys P,
Lansky AJ,
Hermiller J,
Onuma Y,
Miquel-Hebert K,
Yu S,
Veldhof S,
Sood P,
Sudhir K,
Stone G
February 25, 2010
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022